Volume 20, Number 1—January 2014
Synopsis
Severe Fever with Thrombocytopenia Syndrome, Shandong Province, China, 2011
Table 3
Patient no. or parameter |
Day of blood collection after disease onset |
Acute-phase serum samples, n = 24 | Convalescent-phase serum samples, n = 21 | RT-PCR– or ELISA–confirmed SFTSV cases, n = 24 |
||
---|---|---|---|---|---|---|
RT-PCR, S RNA segment |
ELISA titer |
ELISA titer |
||||
1 | 5 | – | 2 | 0 | + | |
2 | 10 | + | 64 | ND | + | |
3 | 6 | – | 0 | 64 | + | |
4 | 4 | – | 0 | 0 | – | |
5 | 9 | – | 256 | ≥512 | + | |
6 | 7 | + | 0 | ≥512 | + | |
7 | 4 | +† | 0 | 128 | + | |
8 | 13 | – | 0 | 128 | + | |
9 | 5 | – | 0 | 0 | – | |
10 | 7 | +† | 0 | 256 | + | |
11 | 6 | – | 0 | 256 | + | |
12 | 6 | + | 64 | ≥512 | + | |
13 | 7 | +† | 0 | ≥512 | + | |
14 | 5 | – | 256 | ≥512 | + | |
15 | 4 | +† | 0 | ≥512 | + | |
16 | 10 | + | 0 | ND | + | |
17 | 6 | + | 32 | 128 | + | |
18 | 13 | – | 512 | NA | + | |
19 | 10 | – | 64 | 256 | + | |
20 | 10 | – | 256 | 256 | + | |
21 | 7 | + | 512 | 256 | + | |
22 | 6 | + | 32 | ≥512 | + | |
23 | 8 | + | 32 | 32 | + | |
24 |
6 |
– |
64 |
256 |
+ |
|
SFTSV positivity rate, % | NA | 50 | 54 | 86 | 92 | |
Sensitivity, % | NA | 55 | 59 | 95 | NA |
* SFTSV positivity rate was calculated by using patients given a clinical diagnosis (n = 24) as the denominator. Sensitivity was calculated by using laboratory-confirmed cases (n = 22) as the denominator. SFTSV, severe fever with thrombocytopenia syndrome virus; RT-PCR, reverse transcription PCR; S, small; –, negative; +, positive; ND, not determined; NA, not applicable.
†Positive by RT-PCR for S and large segments.
1These authors contributed equally to this article.
Page created: January 03, 2014
Page updated: January 03, 2014
Page reviewed: January 03, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.